Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis
Introduction Outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with pre-existing idiopathic pulmonary fibrosis (IPF) remain understudied, and it is unknown if IPF is an independent predictor of worse disease course. Herein, we report the clinical outcomes...
Main Authors: | Syeda Fatima Naqvi, Dhairya A Lakhani, Amir Humza Sohail, James Maurer, Sarah Sofka, Arif Sarwari, Yousaf B Hadi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/8/1/e000969.full |
Similar Items
-
Sedation strategy and ICU delirium: a multicentre, population-based propensity score-matched cohort study
by: Daniel Niven, et al.
Published: (2021-07-01) -
Idiopathic multicentric Castleman’s disease
by: V. I. Vasilyev, et al.
Published: (2020-06-01) -
Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry
by: Jamie L. Todd, et al.
Published: (2019-10-01) -
Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study
by: Takahito Suzuki, et al.
Published: (2021-04-01) -
Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study
by: Chinthaka B. Samaranayake, et al.
Published: (2021-08-01)